Current Neuro-Oncology


Volume 24 Number 17
15 september 2022


Home > Publications > Current Neuro-Oncology > Volume 24, Year 2022 > Number 17, 15 September






Czech C, Chen A, Morgan KP, Zamora C, El-Refai S, Poynter N, Khagi S.
Response to Selpercatinib in a Patient With Recurrent Glioblastoma and RET Amplification.
J Natl Compr Canc Netw. 2022 Sep, 2022;20(9):966-971
. doi: 10.6004/jnccn.2022.7030. PMID: 36075388. Case report.




Huang J, Chan SC, Lok V, Zhang L, Lin X, Lucero-Prisno DE, Xu W, Zheng ZJ, Elcarte E, Withers M, Wong MCS; NCD Global Health Research Group, Association of Pacific Rim Universities (APRU).
Disease Burden, Risk Factors, and Trends of Primary Central Nervous System (CNS) Cancer: a global study of registries data.
Neuro Oncol. 2022 Sep 1, 2022:noac213
. doi: 10.1093/neuonc/noac213. PMID: 36048182. Observational study˰




Iannó MF, Biassoni V, Schiavello E, Carenzo A, Boschetti L, Gandola L, Diletto B, Marchesi E, Vegetti C, Molla A, Kramm CM, van Vuurden DG, Gasparini P, Gianno F, Giangaspero F, Modena P, Bison B, Anichini A, Vennarini S, Pignoli E, Massimino M, De Cecco L.
A microRNA Prognostic Signature in Patients with Diffuse Intrinsic Pontine Gliomas through Non-Invasive Liquid Biopsy.
Cancers (Basel). 2022 Sep 2, 2022;14(17):4307
. doi: 10.3390/cancers14174307. PMID: 36077842. Laboratory investigation.




Shidoh S, Savjani RR, Cho NS, Ullman HE, Hagiwara A, Raymond C, Lai A, Nghiemphu PL, Liau LM, Pope WB, Cloughesy TF, Kaprealian TB, Salamon N, Ellingson BM.
Relapse patterns and radiation dose exposure in IDH wild-type glioblastoma at first radiographic recurrence following chemoradiation.
J Neurooncol. 2022 Sep 2
. doi: 10.1007/s11060-022-04123-3. PMID: 36053452. Observational study.




Truckenmueller P, Graef J, Scheel M, Vajkoczy P, Capper D, Kaul D, Furth C, Amthauer H, Brenner W, Onken JS.
[68Ga]Ga-PSMA PET/MRI, histological PSMA expression and preliminary experience with [177Lu]Lu-PSMA therapy in relapsing high-grade glioma.
Front Oncol. 2022 Sep 2, 2022;12:980058
. doi: 10.3389/fonc.2022.980058. PMID: 36119502. Observational study.




Deacu M, Docu Axelerad A, Popescu S, Topliceanu TS, Aschie M, Bosoteanu M, Cozaru GC, Cretu AM, Voda RI, Orasanu CI.
Aggressiveness of Grade 4 Gliomas of Adults.
Clin Pract. 2022 Sep 3, 2022;12(5):701-713
. doi: 10.3390/clinpract12050073. PMID: 36136867. Observational study.




Conte B, Rich BJ, Gultekin SH, Azzam G, Del Pilar Guillermo Prieto Eibl M.
A Case of Glioblastoma, Isocitrate Dehydrogenase Wild Type, With Widely Disseminated Osseous Metastasis.
Cureus. 2022 Sep 5, 2022;14(9):e28803
. doi: 10.7759/cureus.28803. PMID: 36225424. Case report.



*

Morelli M, Lessi F, Barachini S, Liotti R, Montemurro N, Perrini P, Santonocito OS, Gambacciani C, Snuderl M, Pieri F, Aquila F, Farnesi A, Naccarato AG, Viacava P, Cardarelli F, Ferri G, Mulholland P, Ottaviani D, Paiar F, Liberti G, Pasqualetti F, Menicagli M, Aretini P, Signore G, Franceschi S, Mazzanti CM.
Metabolic-imaging of human glioblastoma live tumors: A new precision-medicine approach to predict tumor treatment response early.
Front Oncol. 2022 Sep 5, 2022;12:969812
. doi: 10.3389/fonc.2022.969812. PMID: 36132155. Observational study.




Snyder MH, Yu-Der Wang A, Ampie L, Sarathy D, Chatrath A, Asthagiri AR, Shaffrey CI, Smith JS, Shaffrey ME, Yen CP, Buchholz AL, Syed HR, Kryzanski J, Wu JK, Heilman CB.
Primary Spinal Cord Astrocytomas: Two Center Clinical Experience of Low- and High-grade Lesions.
World Neurosurg. 2022 Sep 5, 2022:S1878-8750(22)01239-6
. doi: 10.1016/j.wneu.2022.08.130. PMID: 36064118. Observational study˰




Zhang M, Gao L, Liu X, Dong F, Su Q, Zhang Y, Li F, Wang H, Han P.
Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas.
Evid Based Complement Alternat Med. 2022 Sep 5, 2022;2022:3181133
. doi: 10.1155/2022/3181133. PMID: 36106030. Observational study.




Anttonen J, Remes T, Arikoski P, Lähteenmäki P, Arola M, Harila-Saari A, Lönnqvist T, Pokka T, Riikonen P, Sirkiä K, Rantala H, Ojaniemi M.
Pre- and postdiagnosis growth failure, adult short stature, and untreated growth hormone deficiency in radiotherapy-treated long-term survivors of childhood brain tumor.
PLoS One. 2022 Sep 6, 2022;17(9):e0274274
. doi: 10.1371/journal.pone.0274274. PMID: 36067205. Observational study.




Del Baldo G, Carai A, Abbas R, Cacchione A, Vinci M, Di Ruscio V, Colafati GS, Rossi S, Diomedi Camassei F, Maestro N, Temelso S, Pericoli G, De Billy E, Giovannoni I, Carboni A, Rinelli M, Agolini E, Mackay A, Jones C, Chiesa S, Balducci M, Locatelli F, Mastronuzzi A.
Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience.
Ther Adv Med Oncol. 2022 Sep 6, 2022;14:17588359221113693
. doi: 10.1177/17588359221113693. PMID: 36090803. Observational study.




Ostrom QT, Price M, Ryan K, Edelson J, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS.
CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.
Neuro Oncol. 2022 Sep 6, 2022;24(Suppl_3):iii1-iii38
. doi: 10.1093/neuonc/noac161. PMID: 36066969. Observational study.



*

Kumaria A, Noah A, Kirkman MA.
Does covid-19 impair endogenous neurogenesis?
J Clin Neurosci. 2022 Sep 7, 2022;105:79-85
. doi: 10.1016/j.jocn.2022.09.006. PMID: 36113246. Laboratory investigation.




Rades D, Witteler J, Trillenberg P, Olbrich D, Schild SE, Tvilsted S, Kjaer TW.
Increasing Seizure Activity During Radiation Treatment for High-grade Gliomas - Final Results of a Prospective Interventional Study.
In Vivo. 2022 Sep 7, 2022;36(5):2308-2313
. doi: 10.21873/invivo.12961. PMID: 36099095. Interventional study.




Horikawa M, Koizumi S, Oishi T, Yamamoto T, Ikeno M, Ito M, Yamasaki T, Amano S, Sameshima T, Mitani Y, Otani Y, Yan Y, Suzuki T, Namba H, Kurozumi K.
Potent bystander effect and tumor tropism in suicide gene therapy using stem cells from human exfoliated deciduous teeth.
Cancer Gene Ther. 2022 Sep 8
. doi: 10.1038/s41417-022-00527-5. PMID: 36076062. Laboratory investigation˰




Huang X, Hansen J, Lee PC, Wu CK, Federman N, Arah OA, Li CY, Olsen J, Ritz B, Heck JE.
Maternal diabetes and childhood cancer risks in offspring: two population-based studies.
Br J Cancer. 2022 Sep 10
. doi: 10.1038/s41416-022-01961-w. PMID: 36088507. Observational study.




Damodharan S, Helgager J, Puccetti D.
Indolent presentation of a diffuse midline glioma, H3 K27-altered.
Childs Nerv Syst. 2022 Sep 12
. doi: 10.1007/s00381-022-05668-4. PMID: 36094605. Case report˰




Kong BY, Sim HW, Barnes EH, Nowak AK, Hovey EJ, Jeffree R, Harrup R, Parkinson J, Gan HK, Pinkham MB, Yip S, Hall M, Tu E, Carter C, Koh ES, Lwin Z, Dowling A, Simes JS, Gedye C.
Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma.
BMJ Open. 2022 Sep 14, 2022;12(9):e058107
. doi: 10.1136/bmjopen-2021-058107. PMID: 36104135. Interventional study Protocol.




Ballo MT, Qualls KW, Michael LM, Sorenson JM, Baughman B, Karri-Wellikoff S, Pandey M.
Determinants of tumor treating field usage in patients with primary glioblastoma: A single institutional experience.
Neurooncol Adv. 2022 Sep 15, 2022;4(1):vdac150. doi: 10.1093/noajnl/vdac150. PMID: 36249289. Observational study.